Fusion Bioline Vascular Graft, Part number M00201503046B0

FDA Device Recall #Z-1245-2023 — Class II — January 30, 2023

Recall Summary

Recall Number Z-1245-2023
Classification Class II — Moderate risk
Date Initiated January 30, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Maquet Cardiovascular, LLC
Location Wayne, NJ
Product Type Devices
Quantity 1 (US)

Product Description

Fusion Bioline Vascular Graft, Part number M00201503046B0

Reason for Recall

One (1) Fusion Bioline Vascular graft from lot 25162546, which failed guideline straightness testing, was intermingled with lot 25162549 and distributed to customers. Use of the affected graft may result in reduction of blood flow or unwanted tension causing bleeding and the formation of a pseudo-aneurysm.

Distribution Pattern

US Nationwide distribution in the states of FL, IN, LA, MI, MO, NC, NV, NY, PA, TN, TX, VA, WA.

Lot / Code Information

UDI-DI 00384409005942 Lot 25162546

Other Recalls from Maquet Cardiovascular, LLC

Recall # Classification Product Date
Z-2586-2025 Class II Heartstring III Proximal Seal System. Intravas... Aug 15, 2025
Z-2588-2025 Class II Heartstring III Proximal Seal System, 4.3 MM. I... Aug 15, 2025
Z-2587-2025 Class II Heartstring III Proximal Seal System, 3.8 MM. I... Aug 15, 2025
Z-2636-2025 Class II Vasoview Hemopro 3 Endoscopic Vessel Harvesting... Aug 6, 2025
Z-1622-2025 Class II The VASOVIEW HEMOPRO 2 Endoscopic Vessel Harves... Mar 20, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.